fbpx
What can we help you find?

NanoCellect Company History

2011

NanoCellect Biomedical Inc., is incorporated.

https://nanocellect.com/wp-content/uploads/2020/09/BJH_8739-768x768.jpg
https://nanocellect.com/wp-content/uploads/2020/09/BJH_8626-768x768.jpg
https://nanocellect.com/wp-content/uploads/2020/09/BJH_8292-768x768.jpg
https://nanocellect.com/wp-content/uploads/2020/09/Yu-Hwa-Lo-1618x1618-1-768x768.jpg
[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2013

NanoCellect Biomedical Inc. first patent is issued.

https://nanocellect.com/wp-content/uploads/2022/09/Picture1-PZT-and-Sorting-Junction.jpg
[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2015

NanoCellect Biomedical Inc., begins a collaboration with UCSD to develop single cell genomic applications based on their WOLF Cell Sorter.

https://nanocellect.com/wp-content/uploads/2022/09/logo_UCSD.png
[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2016

NanoCellect Biomedical Inc. closes $1.75M Series A financing round and will begin production of their WOLF Cell Sorter.

https://nanocellect.com/wp-content/uploads/2022/08/WOLF-820x610-1-768x571.png

Rick Segil and Jack Ball join the NanoCellect family to gear up for commercial launch of the WOLF Cell Sorter.

https://nanocellect.com/wp-content/uploads/2020/09/jackball_caszhc-1200x1200-1-768x768.jpg

The National Institute on Drug Abuse at the NIH has awarded NanoCellect Biomedical Inc. with a new SBIR Grant aimed at developing an Imaging Flow Cytometer.

NanoCellect Biomedical Inc. officially launches the WOLF Cell Sorter at CYTO 2016.

https://nanocellect.com/wp-content/uploads/2021/08/WOLFN1-High-Res-transparent-768x650.png

The WOLF Cell Sorter is selected as one of the Finalists for Most Innovative New Product Awards by CONNECT.

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2017

NanoCellect Biomedical, Inc. announces its upcoming launch of the N1 Single Cell Dispenser for the WOLF® Cell Sorter.

https://nanocellect.com/wp-content/uploads/2021/06/N1-Single-Cell-Dispensor-Transparent-1772x1738-1-768x753.png

NanoCellect Biomedical Inc. gets $3M from NIH for single cell and image-based flow cytometry.

NanoCellect Biomedical Inc. announces the completion of a $10 million Series B financing round, including convertible notes.

https://nanocellect.com/wp-content/uploads/2022/09/Illumina-Ventures_Logo.png
[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2018

Chris Neary joins NanoCellect Biomedical Inc. as Chief Executive Officer.

https://nanocellect.com/wp-content/uploads/2020/09/BJH_8384-768x768.jpg

NanoCellect Biomedical Inc. extends its footprint in San Diego expanding into additional facilities to accommodate business growth.

NanoCellect Biomedical Inc. presents at Illumina Venture’s annual investor summit.

https://nanocellect.com/wp-content/uploads/2022/09/Illumina-Ventures_Logo.png

NanoCellect Biomedical Inc. announces a new travel award program designed to stimulate novel application of the company’s cell sorting technology.

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2019

NanoCellect Biomedical, Inc. announces that Paul DiGregorio, Ph.D. has joined the company as its new Vice President of Commercial to lead NanoCellect’s global commercial expansion efforts and oversee the company’s sales, marketing, customer support, and product teams.

https://nanocellect.com/wp-content/uploads/2020/11/BJH_8479-768x768.jpg

NanoCellect Biomedical Inc. announces a collaboration with the Parnassus Flow Cytometry Core facility at the University of California, San Francisco (UCSF).

https://nanocellect.com/wp-content/uploads/2022/09/UCSF-768x371.png

NanoCellect Biomedical Inc. announces an exclusive distribution agreement with Basel, Switzerland-based Bucher Biotec AG.

https://nanocellect.com/wp-content/uploads/2022/09/Bucher-Logo.png

NanoCellect Biomedical Inc. announces the selection of Seoul-based DAON BioSciences as exclusive distributor in the South Korea market.

https://nanocellect.com/wp-content/uploads/2022/09/DAON-Bioscience-Logo.png

QIAGEN N.V. and NanoCellect Biomedical, Inc., announces a scientific collaboration to improve the cell sample prep upstream of QIAGEN’s QIAseq® UPX 3′ Transcriptome Kit through the utilization of NanoCellect’s WOLF Cell Sorter technology, which allows for individual cells to be gently sorted into RNAseq- ready 96-well plates.

https://nanocellect.com/wp-content/uploads/2022/09/QIAGEN_Logo-297x500-1.jpg

NanoCellect Biomedical Inc. announces an exclusive agreement with Millennium Science to distribute NanoCellect’s WOLF® Cell Sorter, N1 Single-Cell Dispenser, consumables and software in Australia and New Zealand.

https://nanocellect.com/wp-content/uploads/2022/09/MWSnap-2022-09-15-16_57_47.png

NanoCellect Biomedical, Inc. announces that is has been added to the 10x Genomics’ Compatible Product Partner Program.

https://nanocellect.com/wp-content/uploads/2022/09/10x_Logo_CPP_Horizontal_RGB-1110x373-1-768x258.png

NanoCellect Biomedical, Inc. announces that Jeremy Baker has joined the company as its new Vice President of Finance.

https://nanocellect.com/wp-content/uploads/2020/11/BJH_8508-768x768.jpg

NanoCellect Biomedical Inc. announces it has received a $1.5 million Phase II Small Business Innovation Research (SBIR) grant through the National Institutes of Health’s National Institute on Drug Abuse to continue its development of imaging flow cytometry technology to sort cells based on high-content 3D image features.

https://nanocellect.com/wp-content/uploads/2022/09/SBIR-transparent-768x295.jpg

NanoCellect Biomedical Inc. announces an exclusive agreement with Singapore-based Research Instruments Pte Ltd to distribute NanoCellect’s WOLF® Cell Sorter, N1 Single-Cell Dispenser, consumables and software in Singapore, Thailand, Malaysia, and Vietnam.

https://nanocellect.com/wp-content/uploads/2022/09/Research-Instruments-Logo.jpg

NanoCellect Biomedical Inc. announces an exclusive agreement with Denmark-based RAMCON to distribute NanoCellect’s WOLF® Cell Sorter, N1 Single-Cell Dispenser, consumables and software in Denmark, Finland, Iceland, Norway and Sweden.

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2020

NanoCellect Biomedical Inc. announces a distribution and partnership agreement with China-based Novogene to distribute NanoCellect’s WOLF® Cell Sorter, N1 Single-Cell Dispenser, consumables and software in China.

https://nanocellect.com/wp-content/uploads/2022/09/Novogene-Logo-768x197.png

Akadeum Life Sciences, Inc. and NanoCellect Biomedical, Inc. jointly announce a new collaboration to improve rare-cell workflows.

https://nanocellect.com/wp-content/uploads/2022/09/Akadeum.png

NanoCellect Biomedical Inc. Partners with Filgen for Distribution of Cell Sorting Solutions in Japan.

https://nanocellect.com/wp-content/uploads/2022/09/Filgen-logo200.jpg

NanoCellect Biomedical Inc. announces it has completed agreements with several key partners to distribute its WOLF® Cell Sorter throughout East Asia and Western Europe.

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2021

NanoCellect Biomedical Inc. announces the virtual launch, scheduled for May 18, 2021, of the WOLF G2 Cell Sorter, the newest addition to NanoCellect’s family of products.

https://nanocellect.com/wp-content/uploads/2022/08/WOLF-G2-820x610-1-768x571.png

NanoCellect Biomedical Inc. announces it has completed agreements with two key partners to distribute its WOLF and WOLF G2 Cell Sorters throughout Eastern Europe, Middle East, Africa and Western Asia.

https://nanocellect.com/wp-content/uploads/2021/07/Accella-Logo.png

NanoCellect Biomedical Inc. accelerates growth plans with close of $35 Million in Series C & D Rounds led by Vertical Venture Partners and Warburg Pincus.

https://nanocellect.com/wp-content/uploads/2022/09/VVP-and-Warburg-Pincus-Logo-768x110.png

NanoCellect Biomedical Inc. signs an agreement appointing Alliance Global (AGBL Group) as the exclusive distributor in the Middle East, Africa, Levant, Turkey, Pakistan, Bangladesh and Sri Lanka.

https://nanocellect.com/wp-content/uploads/2022/09/AGBL-logo-new-narrow-1.png
[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2022

Fluent BioSciences and NanoCellect Biomedical Inc. announce joint collaboration to improve resolution of single-cell RNA sequencing analysis of rare cell populations.

https://nanocellect.com/wp-content/uploads/2022/09/Fluent-Bio.png

NanoCellect Biomedical Awarded $1.8M Federal Grant to Advance Imaging Flow Cytometry with Artificial Intelligence Technologies

https://nanocellect.com/wp-content/uploads/2022/09/SBIR-transparent-768x295.jpg
[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

Name(Required)

Name(Required)

Name(Required)

Name(Required)

Name(Required)

Name(Required)

Name(Required)